Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Radioanalytical and Nuclear Chemistry"
DOI: 10.1007/s10967-018-6285-3
Abstract: In this research, we report the labeling and preclinical evaluation of the heterodimer 68Ga-iPSMA-BN ligand regarding its ability to target the prostate-specific membrane antigen (PSMA) and the gastrin-releasing peptide receptor (GRPr) in prostate cancer tumors.…
read more here.
Keywords:
68ga ipsma;
preclinical evaluation;
pet imaging;
prostate cancer ... See more keywords